This new analysis, combining data from the four EWAS that previously allowed us to identify the first two CpGs in AHRR and F2RL3 associated with lung cancer risk with previously unpublished new data from a novel EWAS in EPIC‐Italy, led to the discovery of four additional CpGs and showed that methylation at these CpGs may be useful to improve current risk prediction models based on self‐reported smoking history. Here, AHRR is linked to lung cancer.